Approval · Notice of Compliance 34309 · 2024
DAYBUE: Notice of Compliance 34309
Issued October 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34309
- Date
- October 11, 2024
- Company
- Acadia Pharmaceuticals IncSan Diego, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAYBUE | 02552523 | Marketed |
Medicinal ingredients
- TROFINETIDE 200 MG per ML